Between public and private RPOs

Guideline
Good Publication Practice (GPP) guidelines
To increase the focus on integrity and transparency in industry-sponsored publication planning and development in today’s environment.
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer reviewed journals and presentations (oral or poster) at scientific congresses.
Reference of the resource
W.P. Battisti, E. Wager, L. Baltzer, D. Bridges, A. Cairns, C.I. Carswell, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine 163 (2015) 461-464. doi:10.7326/M15-0288.
Topic:
Declaration of interests
Subopic:
Between public and private RPOs
Type of resource:
Guideline
Relevant discipline(s):
All
Relevant stakeholder(s):
PhD candidates
Early career researchers
Senior researchers
Supervisors
Research administrators
Members of Research Integrity Offices/Bodies
RPO senior management staff (Rectors, Deans)
Funders
Editors
Publishers
Policy makers
Relevant organisational level(s):
System (macro level)
Institution (meso level)
Published/put into force:
2015